Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sastre-Garriga, J.
Right arrow Articles by Thompson, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sastre-Garriga, J.
Right arrow Articles by Thompson, A. J.
Related Collections
Right arrow MRI
Right arrow Clinical trials Methodology/study design
Right arrow Multiple sclerosis
NEUROLOGY 2005;65:633-635
© 2005 American Academy of Neurology
Brief Communications

Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data

J. Sastre-Garriga, MD, G. T. Ingle, MRCP, M. Rovaris, MD, N. Téllez, MD, B. Jasperse, MD, D. R. Altmann, MSc, B. Benedetti, BSc, V. L. Stevenson, MD, M. Cercignani, MPhil, S. M. Leary, MD, F. Barkhof, MD, PhD, B. Brochet, PhD, V. Dousset, PhD, M. Filippi, MD, X. Montalban, MD, PhD, N. F. Kalkers, MD, PhD, C. H. Polman, MD, PhD, À Rovira, MD, PhD, D. H. Miller, FRCP and A. J. Thompson, FRCP

From the NMR Research Unit (Drs. Sastre-Garriga, Ingle, Stevenson, Leary, Miller, and Thompson and D.R. Altmann and M. Cercignani), Institute of Neurology, UCL, London, UK; Neuroimaging Research Unit (Drs. Rovaris and Filippi and B. Benedetti), Department of Neurology, Scientific Institute and University, Ospedale San Raffaele, Milan, Italy; Unitat de Neuroimmunologia Clínica and Unitat de Ressonància Magnètica (Drs. Téllez, Montalban, and Rovira), Institut de Diagnòstic per la Imatge, Hospital General Universitari Vall d'Hebron, Barcelona, Spain; Department of Diagnostic Radiology (Drs. Jasperse, Barkhof, and Kalkers) and Department of Clinical Neurology (Dr. Polman), Free University Hospital, Amsterdam, The Netherlands; Medical Statistics Unit (Dr. Altmann), London School of Hygiene and Tropical Medicine, London, UK; EA 2966 (Drs. Brochet and Dousset), Université Victor Segalen, Bordeaux, France.

Address correspondence and reprint requests to Professor Alan Thompson, Institute of Neurology, UCL, Queen Square, London WC1N 3BG, UK; e-mail: a.thompson{at}ion.ucl.ac.uk.

The authors sought to identify clinical and MRI predictors of outcome in primary progressive multiple sclerosis (PPMS). Clinical and MRI assessments were performed at baseline and 2 and 5 years (clinical only). At baseline, disease duration, expanded disability status scale (EDSS) and brain volume predicted outcome. Adding short-term change variables, baseline EDSS, changes in T2* lesion load and cord area, and number of new lesions were predictive. Clinical and MRI variables predict long-term outcome in PPMS.

Supported by the Spanish Ministry of Health (J.S.G., BEFI #02/9115) and the Wellcome Trust (G.T.I.). The IoN NMR Research Unit is funded by the MS Society of Great Britain and Northern Ireland. This project is an initiative of the E.U. funded MAGNIMS consortium.

Disclosure: The authors report no conflicts of interest.

Received December 3, 2004. Accepted in final form May 5, 2005.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
Z. Khaleeli, D. R. Altmann, M. Cercignani, O. Ciccarelli, D. H. Miller, and A. J. Thompson
Magnetization Transfer Ratio in Gray Matter: A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis
Arch Neurol, November 1, 2008; 65(11): 1454 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J Furby, T Hayton, V Anderson, D Altmann, R Brenner, J Chataway, R. Hughes, K. Smith, D. Miller, and R Kapoor
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis
Multiple Sclerosis, September 1, 2008; 14(8): 1068 - 1075.
[Abstract] [PDF]

Home page
 BrainHome page
O. Ciccarelli, C.A. Wheeler-Kingshott, M.A. McLean, M. Cercignani, K. Wimpey, D.H. Miller, and A.J. Thompson
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis
Brain, August 1, 2007; 130(8): 2220 - 2231.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
F. Agosta, M. Absinta, M. P. Sormani, A. Ghezzi, A. Bertolotto, E. Montanari, G. Comi, and M. Filippi
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
Brain, August 1, 2007; 130(8): 2211 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Rovaris, E. Judica, A. Gallo, B. Benedetti, M. P. Sormani, D. Caputo, A. Ghezzi, E. Montanari, A. Bertolotto, G. Mancardi, et al.
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years
Brain, October 1, 2006; 129(10): 2628 - 2634.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.